{
  "documents": [
    {
      "id": "cluster_19_doc1",
      "content": "Initial diagnostic report confirms moderate obstructive sleep apnea for patient enrolled in employer-sponsored plan. Recommended CPAP therapy with follow-up after 60 days. Sleep study conducted at Nashville General Hospital on 09/15/2023 showed AHI of 28. Provider notes compliance challenges in urban work environment.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_19_doc2",
      "content": "Claims processing memo regarding PT437291 highlights 23-day turnaround for DME authorization, above network average. File indicates coordination between pulmonary department at Nashville General and home health supplier ApexCare regarding CPAP unit model RESmart Auto.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_19_doc3",
      "content": "Provider report from Dr. Helen Marquez details metabolic biomarkers in sleep apnea patients using CPAP. Case PT437291 shows remarkable improvement in blood pressure (142/88 to 128/82) after 8 weeks of therapy. Recommended continued monitoring for cardiovascular comorbidities.",
      "metadata": {
        "format": "provider_report"
      }
    },
    {
      "id": "cluster_19_doc4",
      "content": "Policy update circular modifies coverage criteria for bilevel devices effective Q4 2023. Requires documented failure of CPAP trial for patients with BMI <35. Impacts approximately 18% of active sleep study participants systemwide.",
      "metadata": {
        "format": "policy_document"
      }
    },
    {
      "id": "cluster_19_doc5",
      "content": "Longitudinal research note tracks CPAP adherence metrics among Nashville cohort. Participant 437291 maintained 88% nightly usage (6.2 hrs avg) between October-December 2023. Study correlates >4hrs usage with 32% reduced cardiovascular event risk.",
      "metadata": {
        "format": "research_note"
      }
    },
    {
      "id": "cluster_19_doc6",
      "content": "Patient satisfaction survey from zip 37211 praises NPAP assistance program but criticizes DME supplier response times. Mentions positive experience with respiratory therapist J. Coleman at Nashville General during CPAP fitting.",
      "metadata": {
        "format": "patient_survey"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_19",
    "cluster_risk": "MEDIUM",
    "content_summary": "Middle-aged sleep apnea patient's treatment journey involving CPAP therapy, claims processing, and research participation at Nashville General Hospital during 2023 policy changes",
    "person": {
      "entities": [
        [
          "PT437291",
          "PATIENT_ID"
        ],
        [
          "Nashville General Hospital",
          "LOCATION"
        ],
        [
          "1981-05-23",
          "BIRTHDATE"
        ],
        [
          "Dr. Helen Marquez",
          "PROVIDER"
        ],
        [
          "CPAP therapy",
          "TREATMENT"
        ],
        [
          "09/15/2023",
          "EVENT_DATE"
        ],
        [
          "AHI of 28",
          "UNIQUE_FACT"
        ],
        [
          "37211",
          "INDIRECT_IDENTIFIER"
        ],
        [
          "moderate obstructive sleep apnea",
          "MEDICAL_CONDITION"
        ],
        [
          "CPAP unit model RESmart Auto",
          "UNIQUE_FACT"
        ],
        [
          "88% nightly usage",
          "UNIQUE_FACT"
        ],
        [
          "6.2 hrs avg",
          "UNIQUE_FACT"
        ],
        [
          "blood pressure (142/88 to 128/82)",
          "UNIQUE_FACT"
        ],
        [
          "32% reduced cardiovascular event risk",
          "UNIQUE_FACT"
        ],
        [
          "8 weeks of therapy",
          "UNIQUE_FACT"
        ],
        [
          "60 days follow-up",
          "UNIQUE_FACT"
        ],
        [
          "23-day turnaround for DME authorization",
          "UNIQUE_FACT"
        ],
        [
          "October-December 2023",
          "UNIQUE_FACT"
        ]
      ]
    },
    "questions": [
      {
        "q": "What was patient PT437291's apnea-hypopnea index during the September 2023 sleep study?",
        "a": "The sleep study showed an AHI of 28.",
        "sources": [
          "cluster_19_doc1"
        ],
        "type": "specific"
      },
      {
        "q": "What cardiovascular improvement was observed after 8 weeks of CPAP use for sleep apnea patients?",
        "a": "Blood pressure improved from 142/88 to 128/82.",
        "sources": [
          "cluster_19_doc3"
        ],
        "type": "general"
      },
      {
        "q": "Which provider and facility managed PT437291's CPAP treatment and research participation?",
        "a": "Dr. Helen Marquez at Nashville General Hospital.",
        "sources": [
          "cluster_19_doc1",
          "cluster_19_doc3"
        ],
        "type": "specific"
      },
      {
        "q": "How did 2023 policy changes impact device authorization requirements for sleep apnea patients and what effect did it have on CPAP adherence among participants?",
        "a": "Policy required documented CPAP failure; adherence stayed at 88%.",
        "sources": [
          "cluster_19_doc4",
          "cluster_19_doc5"
        ],
        "type": "general"
      }
    ]
  }
}